CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway

Table 2 Relationship between CHRNB2 expression and clinical information in pancreatic cancer patients

Variables	CHRNB2		Total	P value
Variables	Low(n = 89)	High(n = 89)	Total	P value
Sex
Female	40	40	80	1
Male	49	49	98	1
Age
≤ 65	46	47	93	1
> 65	43	42	85	1
T Stage
T1&T2	7	24	31	0.002^**
T2&T3	82	63	145	0.002^**
LNR
Low	36	50	86	0.0328^*
High	50	36	86	0.0328^*
M stage
M0	38	41	79	1
M1	2	3	5	1
Histological grade
G1&G2	61	65	126	0.328
G3&G4	26	24	50	0.328
Tumor location
Head	73	65	138	0.209
Non-head	16	24	40	0.209
Somker
No	32	33	65	0.65
Yes	43	36	79	0.65
Alcohol history
No	30	35	65	0.609
Yes	52	49	101	0.609
Diabetes history
No	54	54	108	0.928
Yes	20	18	38	0.928
Chronic pancreatitis history
No	61	67	128	0.085
Yes	10	3	13	0.085
Family history of cancer
No	25	22	47	0.474
Yes	28	35	63	0.474

ISSN: 1475-2867